Professor, Pediatrics, USC School of Medicine
Pediatric Infectious Disease
Dr. Andrea A. Kovacs, MD
|
|
Give Review
Andrea Kovacs practices Pediatric Infectious Disease. She attended New York Medical College. She received 2 awards: "Fellow (FAAP)" and "Super Doctor". Andrea Kovacs is a published doctor. She has 68 papers published. The most current publication "Seasonality and factors associated with cryptosporidiosis among individuals with HIV infection."
Publications
- Highly efficient star formation in NGC 5253 possibly from stream-fed accretion.
- Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.
- Association of Chronic Hepatitis C Infection With T-Cell Phenotypes in HIV-Negative and HIV-Positive Women.
- T-Cell Activation, Both Pre- and Post-HAART Levels, Correlates With Carotid Artery Stiffness Over 6.5 Years Among HIV-Infected Women in the WIHS.
- Genital Tract HIV RNA Levels and Their Associations with Human Papillomavirus Infection and Risk of Cervical Pre-Cancer.
- Alteration of select gene expression patterns in individuals infected with HIV-1.
- Effect of protease inhibitors on steady state pharmacokinetics of oral norethindrone contraception in HIV infected women.
- Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
- Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.
- The Effect of Prenatal Highly Active Antiretroviral Therapy (HAART) on the Transmission of Congenital and Perinatal/Early Postnatal Cytomegalovirus (CMV) Among HIV-Inf...
- Permissive and Protective Factors Associated With Presence, Level, and Longitudinal Pattern of Cervicovaginal HIV Shedding.
- HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women.
- HIV type 1 and cytomegalovirus coinfection in the female genital tract.
- Effect of Cytomegalovirus Co-Infection on Normalization of Selected T-Cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiret...
- Correlates of perinatal depression in HIV-infected women.
- Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).
- Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
- Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.
- Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine...
- Seasonality and factors associated with cryptosporidiosis among individuals with HIV infection.
- HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.
- Epidemiology of Pneumocystis colonization in families.
- The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
- CCR2 genotype and disease progression in a treated population of HIV type 1-infected women.
- HIV-1 and immune control: can we change the course of HIV-1?
- Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.
- Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
- The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.
- Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.
- Voriconazole pharmacokinetics and pharmacodynamics in children.
- Antiretroviral therapies associated with lipoatrophy in HIV-infected women.
- Management of antiretroviral therapy in neonates, children, and adolescents.
- Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load res...
- Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays.
- Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection.
- Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.
- Molecular and epidemiologic evaluations of a cluster of cases of Ménétrièr's disease associated with cytomegalovirus.
- Single-dose safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, in HIV-infected children.
- Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.
- Using social networks to recruit an HIV vaccine preparedness cohort.
- The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-Infected and HIV-Uninfected Women.
- The role of race and gender in T cell responses in children perinatally infected with HIV-1.
- CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
- Increased circulating interleukin-7 levels in HIV-1-infected women.
- Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.
- HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.
- CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
- HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.
- Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women.
- Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
- Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient popul...
- Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
- Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
- Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women.
- Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
- CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus.
- Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expressi...
- Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.
- Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.
- The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.
- CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy.
- Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
- Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.
- Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.
- Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.
- Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
- Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
Schools
New York Medical College
Lac Usc Med Center
N Shore University Hospital
Usc Med Center
City Hope National Med Center Usc
City Hope National Med CtrUsc
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Fellow (FAAP)
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
New York Medical College
Hospital
-
Huntington Memorial Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Yvonne J. Bryson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Santhosh M. Nadipuram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel A. Streng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary D. Burkhart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime G. Deville, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wilbert H. Mason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pia S. Pannaraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Zaia, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nava Yeganeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret M. Khoury, MD |
|
|
Dr. Paul A. Krogstad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikram Anand, MD
This Doctor is OpenDoctor Recommended.
|